Drugs Channel
Topics & Medications
Quicklinks
Related Channels

Ivacaftor Drug Information

A healthcare provider may prescribe ivacaftor (KalydecoTM) to treat cystic fibrosis in adults or children as young as six years old. This product comes in the form of tablets that are taken once daily, twice daily, or twice a week, depending on factors like your age and how well your liver is functioning.
 
This medication is not approved for everyone who has cystic fibrosis. Ivacaftor is only approved for people who have a certain type of gene mutation called the G551D mutation of the CF gene.
 
Studies have shown that this is an effective medicine; however, it's not suitable for everyone. Safety information on ivacaftor should be reviewed with your healthcare provider before taking this drug to help ensure a safe treatment. For instance, people who have certain allergies, those taking certain medications, or people with liver or kidney disease may not be able to safely use ivacaftor.
 
(Click Ivacaftor for more details on this drug, including information on how it performed in clinical trials, why it should be taken with a high-fat meal, and how it works.)
 

Ivacaftor Drug Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2018 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.